Humana Inc (NYSE:HUM) stock rose 7% on Thursday following the company’s update on Medicare star ratings, which showed progress in its strategic initiatives to improve performance metrics.
Humana’s stock spiked after the health insurer disclosed some findings from the government’s Star Ratings for its 2026 Medicare Advantage plans.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $299.33, with a high estimate of $344.00 and a low estimate of $260.00. Marking an increase ...
Humana navigates Medicare Advantage challenges with strategic shifts and stable guidance. Learn more about HUM's outlook and ...
The upcoming report from Humana (HUM) is expected to reveal quarterly earnings of $6.32 per share, indicating a decline of 9.2% compared to the year-ago period. Analysts forecast revenues of $31.78 ...
UnitedHealth Group Incorporated UNH has staged a sharp comeback, with shares climbing 12% over the past month, trimming its ...
Zacks Investment Research on MSN

Is Humana (HUM) Stock Undervalued Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...
Humana Inc.'s shares up 21%, but it is facing near-term headwinds from Medicare Advantage ratings and profit outlook. Read ...
Shares of Humana Inc. were rallying in early Wednesday trading, after the health insurer reported solid second-quarter results and raised its full-year earnings outlook above Wall Street expectations ...
The benchmark index eked out a fractional gain to close at a record high Friday with a boost from health insurance stocks, ...
Humana Inc. (NYSE:HUM) ranks among the stocks with low beta that can beat market volatility. On September 22, Evercore ISI ...